SEC Form 4 · accession 0001209191-18-017154

Xylem Inc. · XYL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior Vice President

Period of report

Mar 5, 2018

Accepted (ET)

Mar 6, 2018 · 3:13 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001524472

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 5, 2018	M	3,986	$35.96	A	15,848	D
Common Stock^F1	Mar 5, 2018	S	3,986	$73.45	D	11,862	D
Common Stock	Mar 5, 2018	M	2,772	$37.47	A	14,634	D
Common Stock^F1	Mar 5, 2018	S	2,772	$73.45	D	11,862	D
Common Stock	Mar 5, 2018	M	3,913	$48.33	A	15,775	D
Common Stock^F1	Mar 5, 2018	S	3,913	$73.45	D	11,862	D
Common Stock	Mar 5, 2018	S	1,045	$73.47	D	10,817	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F2	$35.96	Mar 5, 2018	M	3,986	D	—	Feb 24, 2025	Common Stock	3,986	0	D
Employee Stock Option (Right to Buy)^F3	$37.47	Mar 5, 2018	M	2,772	D	—	Feb 24, 2026	Common Stock	2,772	2,771	D
Employee Stock Option (Right to Buy)^F4	$48.33	Mar 5, 2018	M	3,913	D	—	Feb 21, 2027	Common Stock	3,913	7,824	D

F1This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $73.44 to $73.52 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F2These options are fully vested and exercisable.
F3These options vest in 3 equal annual installments beginning on February 24, 2017.
F4These options vest in 3 equal annual installments beginning on February 21, 2018.